Market revenue in 2020 | USD 1,558.9 million |
Market revenue in 2028 | USD 2,164.1 million |
Growth rate | 4.2% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Consumables, Services |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.63% in 2024. Horizon Databook has segmented the UK infectious respiratory disease diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
The UK is one of the key markets for infectious respiratory disease diagnostics in Europe. The market in UK is expected to grow at a CAGR of 4.2% during the forecast period due to presence of established healthcare system, high disposable income, and rise in awareness levels about early diagnosis of diseases.
Increasing incidence of antibiotic-resistant infections is also expected to drive market growth in the country. For instance, according to an English Surveillance Program for Antimicrobial Utilization and Resistance report, about 65,162 cases of antibiotic-resistant infections, including drug resistant tuberculosis, were reported in England in 2019.
Early detection of viruses such as H1N1, RSV, and SARS-CoV-2 is gaining traction in the UK. Government in this country is undertaking several infectious disease testing initiatives to detect specific disease causing microorganisms and prevent communicable diseases.
Horizon Databook provides a detailed overview of country-level data and insights on the UK infectious respiratory disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into UK infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account